Commonly used anti-rejection drug could be repurposed to treat some liver cancers
Research from the University of Pittsburgh School of Medicine in animal models and patient tissues has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be repurposed ...
Jan 31, 2019
0
46